Principle Investigator(s): Lee Shulman, MD & Shohreh Shahabi, MD

Manager: Kisha Hope kisha.hope@northwestern.edu

IRB Protocol Name: NU 99G8: Northwestern Ovarian Cancer Early Detection and Prevention Program: A Specimen and Data Study

IRB Protocol Number: STU00005421

Description: 

The aim of the Northwestern Ovarian Cancer Early Detection & Prevention Program (NOCEDPP):  A Specimen and Data Study is to establish an effective, early detection program employing state-of-the-art science and technology in collaboration with other nationally recognized clinicians and scientists.  This proposed research study will foster collaboration between clinicians and scientists that will facilitate the rapid identification of a set of molecular, biochemical, functional, and genetic markers which can be employed to effectively detect and manage ovarian cancer and other gynecological malignancies.

• To identify and develop highly sensitive and specific tumor markers for the detection and management of ovarian cancer and other gynecological malignancies.
• To identify new prevention approaches and therapies.
• To identify measures to improve the quality of life for women at increased risk for developing ovarian cancer and for women diagnosed with ovarian cancer.

IRB Process: IRB approval or exemption must be obtained prior to release of data or specimens. The request form will ask you input your IRB number or declare your IRB exemption.

Scientific Justification: The request form will ask you to attach a 'Methods/Justifications' document that should contain a scientific explanation justifying the disbursement of the clinical data and/or clinical specimens.